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Abstract
Lipid rafts are known to regulate several membrane functions such as signaling, trafficking and cellular adhesion. The local
enrichment in sphingolipids and cholesterol together with the low protein content allows their separation by density
gradient flotation after extraction with non-ionic detergent at low temperature. These structures are also referred to as
detergent resistant membranes (DRM). Among sphingolipids, gangliosides play important roles in different biological
events, including signal transduction and tumorigenesis. Sialidase NEU3 shows high enzymatic specificity toward
gangliosides. Moreover, the enzyme is present both at the cell surface and in endosomal structures and cofractionates with
caveolin. Although changes in the expression level of NEU3 have been correlated to different tumors, little is known about
the precise distribution of the protein and its ability in modifying the ganglioside composition of DRM and non-DRM, thus
regulating intracellular events. By means of inducible expression cell system we found that i) newly synthesized NEU3 is
initially associated to non-DRM; ii) at steady state the protein is equally distributed between the two membrane
subcompartments, i.e., DRM and non-DRM; iii) NEU3 is degraded via the proteasomal pathway; iv) the enzyme specifically
modifies the ganglioside composition of the membrane areas where it resides; and v) NEU3 triggers phosphorylation of Akt,
even in absence of exogenously administered EGF. Taken together our data demonstrate that NEU3 regulates the DRM
ganglioside content and it can be considered as a modulator of Akt phosphorylation, further supporting the role of this
enzyme in cancer and tumorigenesis.
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Introduction
The lipid and protein components of cellular membranes can be
laterally segregated, giving rise to specialized functional structures
named lipid rafts, known to play important roles in regulating
several membrane functions such as signaling, trafficking and
cellular adhesion [1]. Lipid rafts represent dynamic liquid-liquid
immiscibility entities, thus membrane subcompartmentalization.
They are dynamic fluctuating nanoscale assemblies of sphingolip-
ids, cholesterol and proteins that dissociate and associate usually
on a rapid timescale. The relatively few proteins present in these
areas are mainly represented by GPI-anchored proteins, members
of the Src-family tyrosine kinases, cholesterol-binding proteins
such as caveolins, and heterotrimeric G-proteins [1,2]. The high
concentration in sphingolipids and cholesterol together with the
low protein content in lipid rafts determine their low density and
insolubility in presence of non-ionic detergents, thus they are also
referred as detergent resistant membranes (DRM) [3]. Detergent
treatment at low temperature allows the solubilization of the
‘‘liquid disordered’’ bilayer, generally without interfering with the
structure and composition of the ‘‘liquid-ordered’’ sub-compartment.
Gangliosides are sialic acid containing sphingolipids present in
the outer leaflet of the membrane, known to play important roles
in different biological events, including cell-to-cell, cell-to-envi-
ronment interactions and signal transduction. Among gangliosides,
GM3 binds to EGFR, regulating its activity [4,5]. The membrane
ganglioside pattern is the result of the correct balance between
their synthesis, mediated by sialyl-transferases, and degradation,
which is mediated by sialidases (NEUs). Among sialidases, NEU3
was initially identified as the membrane-associated member of the
sialidase family enzyme, showing high enzymatic specificity
toward gangliosides, especially GM3 and GD1a [6–9]. Moreover,
NEU3 is a peripheral membrane protein present both at the cell
surface and in endosomal structures [10], known to cofractionate
with caveolin [11]. Although up-regulation of NEU3 has been
correlated to different tumors [12,13], little is known about the
precise distribution of the protein in relation to membrane sub-
compartments, i.e. DRM and non-DRM, and its ability in
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modifying the ganglioside composition of these membrane
compartments, thus regulating intracellular events.
By means of inducible expression cell system we found that i)
newly synthesized NEU3 is initially associated to non-DRM; ii) at
steady state the protein is equally distributed between the two
membrane subcompartments; iii) NEU3 is degraded via the
proteasomal pathway; iv) the enzyme specifically modifies the
ganglioside composition of the membrane areas where it resides,
and v) NEU3 triggers phosphorylation of Akt, even in absence of
exogenously administered EGF.
Taken together our data indicate that sialidase NEU3 is the
enzyme responsible for the modifications of the ganglioside
composition both in DRM and in non-DRM and can be
considered as a modulator of Akt phosphorylation, further
supporting its role in cancer and tumorigenesis.
Materials and Methods
Chemicals and reagents
All chemicals are molecular biology-grade (SIGMA-Aldrich)
unless specified, common solvents were from Merck. High
performance silica gel-precoated thin-layer plates (HPTLC
Kieselgel 60) were purchased from Merck GmbH. [3-3H]Sphin-
gosine (specific radioactivity 19.8 Ci/mmol) was provided by
PerkinElmer Life Sciences.
Antibodies
For immunoblotting experiments, the following primary anti-
bodies were used: rabbit anti-HA 1:1000 (Sigma), mouse anti-TfR
(transferrin receptor) 1:400 (Invitrogen), rabbit anti-Cav-1 (caveo-
lin-1) 1:250 (Santa Cruz Biotechnology), mouse anti-a-tubulin
1:16000 (Sigma), mouse anti-ERK1/2 1:1000 (Santa Cruz
Biotechnology) and mouse anti-phosphoERK1/2 (Tyr204)
1:1000 (Santa Cruz Biotechnology), rabbit anti-Akt1/2/3 1:4000
(Cell Signaling) and rabbit anti-phosphoAkt (Thr308) 1:4000 (Cell
Signaling). HRP (horseradish peroxidase)-conjugated donkey anti-
rabbit and sheep anti-mouse secondary antibodies 1:5000 (GE
Healthcare) were used.
Plasmid preparation
pcDNA1/Amp MmNEU3-HA, gently provided by Dr. T.
Miyagi (Institute of Molecular Biomembrane and Glycobiology,
Tohoku Pharmaceutical University, Sendai, Miyagi, Japan) and
already used in previous works, was mutagenized in order to insert
downstream the HA-epitope the following restriction sites: BglII,
SacII and XbaI. pEGFP-C2 (Clontech) was used to amplify the
GFP coding sequence by PCR using amplification oligonucleo-
tides carrying a BglII site at 59 and a SacII site at 39. The amplified
GFP sequence was initially subcloned into the mutagenized
pcDNA1/MmNEU3-HA and subsequently the whole ORF
MmNEU3–HA-GFP was excised and subcloned into the pUHD
10.3 plasmid [14] using the 59 EcoRI site and the 39 XbaI site.
pUHD 10.3/MmNEU3-HA-GFP was then mutagenized in order
to prepare a second NEU3 expressing plasmid without GFP. For
this purpose we inserted a BglII restriction site downstream the
GFP epitope and used it for the excision of GFP and subsequent
ligation, obtaining the pUHD 10.3/MmNEU3-HA plasmid.
Cell culture and transfection
Hela tTA2 cells, over-expressing the Tetracycline transactivator
(Tet-OFF), were gently provided by S. Schmidt (Scripps Institute,
S. Diego, CA, USA) [15] and were cultured in high glucose
DMEM (Dulbecco’s modified Eagle’s medium) (EuroClone)
containing 4 mM L-glutamine, 100 units/ml penicillin, 100 mg/
ml streptomycin and 10% (v/v) fetal bovine serum (FBS) and
0.25 mg/ml G418, and were maintained at 37uC and 5% CO2 in
a humidified incubator. Cells were stably co-transfected with
pUHD 10.3 NEU3–HA-GFP and pSV2-pac or pUHD 10.3
NEU3-HA and pHygro plasmids in a ratio 40:1, respectively.
Mock cells were obtained by transfection with pSV2-pac or
pHygro plasmids alone. Transfection was performed in serum-free
medium OptiMEM (Life Technologies) employing FuGENE 6
(Roche). After 6 h transfection the medium was changed to
complete medium (DMEM+10% FBS+0.25 mg/ml G418) and
after further 48 h resistant clones were selected by addition of
puromycin (2 mg/ml) or hygromycin (200 mg/ml) to the growth
medium. Puromycin- and hygromycin-resistant clones were
isolated and tested for NEU3 enzymatic activity and for intensity
of GFP fluorescence, the latter only for NEU-HA-GFP clones; the
most homogeneous and enzymatically active clones were used in
this study and were cultured in high glucose DMEM containing
4 mM L-glutamine, 100 units/ml penicillin, 100 mg/ml strepto-
mycin, 10% (v/v) fetal bovine serum (FBS), 0.25 mg/ml G418,
0.5 mg/ml puromycin or 200 mg/ml hygromycin, and 1 ng/ml
doxycycline (dox). Medium containing dox was replaced every
48 hours. Expression of NEU3-HA-GFP and NEU3-HA was
achieved by removing dox from culture medium.
Sialidase activity assay
The enzymatic activity of HeLa tTA2 NEU3-HA-GFP and
HeLa tTA2 NEU3-HA cells, treated or not with dox, was
determined as described previously [7] using 0.1 mM 4 MU-
NeuAc (4-methylumbelliferyl-N-acetyl-a-D-neuraminic acid) as
substrate.
Immunoblotting
Proteins were separated by SDS/10% PAGE and transferred to
a Hybond-P PVDF membrane (GE Healthcare). Membranes were
then blocked with 5% (w/v) non-fat dried skimmed milk in PBS,
washed three times with PBS containing 0.1% Tween 20 (PBST)
and incubated with primary antibody diluted in PBST containing
1% (w/v) non-fat dried skimmed milk for 1 h at room
temperature. After three washes with PBST, membranes were
incubated with HRP-conjugated secondary antibody diluted in
PBST for 45 min at room temperature. Detection of the
immunocomplexes was performed using the enhanced chemilu-
minescence-based system (SuperSignal West Pico Chemilumines-
cent Substrate; Pierce), followed by densitometric analysis using
GelPro 3.1 software (Media Cybernetics).
RNA extraction and real-time RT-PCR
Total RNA was extracted from cells using the RNeasy mini kit
(Qiagen), according to the manufacturer’s protocol. The iScript
cDNA Synthesis Kit (Bio-Rad Laboratories) was used to reverse-
transcribe 0.8 mg of RNA. Real time PCR was performed by the
iCycler thermal cycler (Bio-Rad Laboratories) using cDNA
corresponding to 10 ng of total RNA as template. PCR mixture
included 0.2 mM primers, 50 mM KCl, 20 mM Tris/HCl pH 8.4,
0.8 mM dNTPs, 0.7 U iTaq DNA Polymerase, 3 mM MgCl2,
and SYBR Green (iQ SYBR Green Supermix from Bio-Rad
Laboratories) in a final volume of 20 ml. Amplification and real
time data acquisition were performed using the following cycle
conditions: initial denaturation at 95uC for 3 min, followed by 40
cycles of 10 s at 95uC and 30 s at 58uC. The fold change in
expression of the different genes in NEU3-HA-GFP overexpress-
ing cells compared with Mock cells was normalized to the
expression of glyceraldeide 3-phosphate dehydrogenase (GAPDH)
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mRNA and was calculated by the equation 22DDCt with iQ5
Software Version 2.0 (Bio-Rad). All reactions were performed in
triplicate. The primers used were: HsNEU1: Fw 59-CCTGGA-
TATTGGCACTGAA-39 and Rev 59-CATCGCTGAGGAGA-
CAGAAG-39; HsNEU3: Fw 59-TGAGGATTGGGCAGTTGG-
39 and Rev 59-CCCGCACACAGATGAAGAA-39; HsGAPDH:
Fw 59-AGGGCTGCTTTTAACTCTGG-39 and Rev 59-
CATGGGTGGAATCATATTGG-39. The accuracy was moni-
tored by the analysis of the melting curves.
Metabolic labeling of cell sphingolipids
[3-3H]Sphingosine dissolved in ethanol was transferred into a
glass sterile tube and dried under a nitrogen stream; the residue
was then dissolved in an appropriate volume of pre-warmed
DMEM+10% FBS to obtain a final concentration of 0.25 mCi/
100 mm dish (corresponding to 2.661029 M). OFF and ON
HeLa tTA2 NEU3-HA-GFP cells were incubated with DMEM+
10% FBS containing [3-3H]Sphingosine. After a 2 h incubation,
the medium was removed and cells were chased for 48 h with
DMEM+10% FBS, always containing or not dox, in order to
reach the metabolic steady state. This condition was previously
established with ad hoc experiments. At the end of chase, cells
were washed and harvested in ice-cold phosphate-buffered saline
(PBS) by scraping. Cell suspensions were frozen and then
lyophilized.
Extraction and analysis of radioactive lipids
Total lipids from lyophilized cells were extracted twice with
chloroform/methanol/water 20:10:1 (v/v). Lipid extracts were
dried under a nitrogen steam, dissolved in chloroform/methanol
2:1 (v/v) and subjected to a two-phase partitioning in chloroform/
methanol 2:1 and 20% (v/v) water. The aqueous and organic
phases obtained were counted for radioactivity and analyzed by
HPTLC. [3H]Sphingolipids of organic phase were separated using
the solvent system chloroform/methanol/water 55:20:3 (v/v). The
solvent system chloroform/methanol/0.2% aqueous CaCl2
60:40:9 (v/v) was employed to analyze [3G]Sphingolipids of
aqueous phase. Radioactive lipids were visualized with a Beta-
Imager 2000 (Biospace, Paris, France) and identified by compar-
ison with radiolabeled standards. The radioactivity associated with
individual lipids was determined with the specific b-Vision
software (Biospace, Paris, France).
Preparation of soluble and membrane-associated protein
fractions
DRM preparation was adapted from a previously described
procedure with minor modifications [16]. Adherent cells were
washed twice with cold PBS, scraped from the dishes, gently
resuspended in TNE buffer (20 mM Tris-HCl pH 7.5, 150 mM
NaCl, 1 mM EDTA) supplemented with cold 1% Triton X-100
(TNE-TX) and a protease inhibitor cocktail, and extracted for
30 min on ice. Cell extracts were further processed in two different
manners, as described below.
Crude separation. One third of the cell extracts was
withdrawn and kept as total fraction, and the residual two thirds
was centrifuged at 100,0006g for 1 h with a Beckman 50Ti rotor.
Pelleted material was resuspended in the same volume of the
supernatant with TNE-TX buffer. Aliquots of the total, pellet and
supernatant fractions were used for Western blot analysis [17].
OptiPrep Gradient Separation. Cell extracts were adjusted
to 40% v/v OptiPrep in a final volume of 1.1 ml, placed at the
bottom of a 4-ml ultracentrifuge tube and overlaid with 2 ml 30%
OptiPrep and 0.9 ml 5% Optiprep step gradient. All dilutions
were performed in TNE-TX buffer. After ultracentrifugation
(170,0006g, 4uC, 4 h; Beckman SW50.1 rotor), fractions of 500 ml
were collected from the top and processed for further analyses
[3,18].
Sphingolipid pattern modification during time-
dependent sialidase expression
To assess NEU3-HA-GFP and NEU3-HA activity toward
gangliosides of DRM and non-DRM areas during time-dependent
sialidase expression, we performed a metabolic labelling with
[3-3H]Sphingosine and then DRM and non-DRM fractions were
separated on a Optiprep density gradient. In brief, NEU3-HA-
GFP and NEU3-HA cells in presence of dox were treated with
[3-3H]Sphingosine according to the usual protocol. For each
sample, 5 dishes each of 100 mm diameter were used. After a 24 h
chase, dox was removed and cells were cultured for different time
periods. At the end of incubation cells were harvested and lysed in
TNE-TX containing a protease inhibitor cocktail, for 20 min on
ice. Cell lysates were adjusted to 40% v/v OptiPrep in a final
volume of 3.3 ml, placed at the bottom of ultracentrifuge tube and
overlaid with 6 ml 30% OptiPrep and 2.7 ml 5% Optiprep step
gradient. After ultracentrifugation (170,0006g, 4uC, 4 h; Beck-
man SW41 Ti rotor), fractions of 1.5 ml, except for the first
fraction (1.2 ml), were collected from the top to the bottom of the
gradient, 4/5 volume of each fraction was employed to analyze
[3H]Sphingolipid pattern. The rest was processed for sialidase
activity and western blotting analyses. Ganglioside and other
sphingolipids were extracted, separated and quantified as
described previously.
Cell stimulation with EGF
OFF NEU3-HA-GFP cells were plated and maintained in
serum-free medium for 24 h before harvesting. At the same time,
expression of NEU3-HA-GFP was allowed for different time
periods (8, 24, 48 and 72 h). Before harvesting cells were
stimulated or not with 100 ng/ml EGF for 10 min. After
stimulation cells were washed twice with cold PBS and then lysed
for 15 min at 4uC in lysis buffer (25 mM Tris-HCl pH 7.4,
150 mM NaCl, 5 mM EDTA, 20 mM NaF, 1 mM Na3VO4,
0.5% (v/v) NP40, 10 mg/ml leupeptin, 10 mg/ml aprotinin, 1 mg/
ml pepstatin A). Insoluble material was removed by centrifugation
at 13,0006g for 10 , supernatants were collected and assayed for
protein concentration with Coomassie Protein Assay (Pierce).
Western blot analysis for the different intracellular signaling
molecules was performed using aliquots deriving from the same
cell extracts.
Confocal microscopy analysis
Subcellular distribution analysis of NEU3-HA-GFP was per-
formed as described previously [7], with minor modifications. ON
HeLa tTA2 NEU3-HA-GFP expressing cells were seeded onto
glass coverslips and after 48 h were grown for 8 h in medium
containing dox supplemented or not with 5 mM MG132, or for
6 h in medium containing dox and 5 mMMG132, followed by 2 h
chase in medium without MG132. Cells were then washed three
times with PBS containing 1 mM MgCl2 and 1 mM CaCl2
(PBS++) and fixed with 3% (w/v) paraformaldehyde containing 2%
sucrose in PBS++ for 15 min at room temperature. Paraformal-
dehyde was then quenched by incubating samples with 50 mM
NH4Cl in PBS
++ for 15 min. Finally, specimens were washed three
times with PBS++, mounted using DakoCytomation Fluorescent
Mounting Medium and analyzed with confocal system LSM-510
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META (Carl Zeiss). Images were processed with LSM Image
Browser (Carl Zeiss) and Adobe Photoshop software.
Statistical data analysis
Data are the means 6 standard deviations (S.D.). Statistical
analysis were made using unpaired Student’s t test. Significance
was attribute at the 95% level of confidence (P-value ,0.05).
Results
Inducible expression of NEU3-HA-GFP
In order to study the membrane association and distribution of
sialidase NEU3 during its biosynthesis we expressed the murine
enzyme protein under controlled experimental conditions, taking
advantage of the tetracycline inducible expressing system. We
introduced the EGFP coding sequence at the C-terminus of the
already available plasmid pcDNA1-NEU3-HA expressing the
mouse sialidase NEU3 tagged to the HA epitope [7,10], and the
resulting ORF of the chimeric protein NEU3-HA-GFP was then
subcloned in the pUHD-10.3 plasmid and used to stably transfect
HeLa tTA2 cells, expressing the tetracycline-controlled transacti-
vator protein tTA. This is expected to result in the cell model
HeLa tTA2 NEU3-HA-GFP where the expression of the enzyme
is constitutive in absence of the tetracycline-derivative doxycycline
(dox) and, on the other hand, expression of the chimeric protein
would be null in presence of dox. To verify these aspects, HeLa
tTA2 NEU3-HA-GFP transfected cells cultivated in presence of
1 ng/ml dox were plated and grown for further 7 days in absence
(ON) or presence (OFF) of dox and tested for their sialidase
activity and protein expression. Crude homogenates deriving from
ON cells showed a 16-fold increase in sialidase activity measured
with the artificial substrate 4-MU-NeuAc and compared to the
endogenous enzymatic activity measured in mock-transfected
HeLa tTA2 cells, corresponding to 130.39+/211.49 and
7.88+/22.32 nmols h21 mg Prot21, respectively (Figure 1A). As
expected, crude homogenates deriving from the same clone and
grown in presence of dox (OFF) showed sialidase activity
comparable to mock HeLa tTA2 cells, indicating that expression
of NEU3-HA-GFP is indeed regulated by the presence of dox in
the growth medium. In order to confirm that the increase in
sialidase activity results from the overexpression of the chimeric
protein, equal protein amounts of cell extracts were analyzed by
western blot using anti-HA primary antibody. As shown in
Figure 1A, a protein band of the expected molecular weight of the
NEU3-HA-GFP chimera protein and corresponding to 78 kDa
was detected only in cell extracts deriving from ON HeLa tTA2
NEU3-HA-GFP cells. These data demonstrate that in our cell
system, expression of NEU3-HA-GFP is strictly under the control
of the tetracycline promoter.
This finding prompted us to further characterize our cell system
and to investigate the time course of NEU3-HA-GFP expression.
OFF HeLa tTA2 NEU3-HA-GFP cells were plated and grown for
different time periods under permissive conditions. Removal of
dox resulted in the increase of sialidase activity in the cell
homogenates (Figure 1B). Under these experimental conditions,
after 18 h expression cells reached 50% of sialidase activity
measured in ON cells while full activity was achieved after 72 h
expression. Is worth to note that the increase in sialidase activity
correlates with densitometric analysis of the specific protein bands
detected in cell homogenates, normalized to the alpha-tubulin
signal of each sample (Figure 1B, inset). We then investigated
NEU3-HA-GFP degradation kinetic and for this purpose, ON
HeLa tTA2 NEU3-HA-GFP cells were plated and cultivated for
different time periods in presence of dox. A fast decrease in
sialidase activity in total homogenates was observed (Figure 1C),
correlating with the densitometric analysis of the immunoreactive
bands detected by western-blot (Figure 1C, inset). More detailed,
after 24 h in presence of dox, sialidase activity was almost
comparable to the residual endogenous activity measured in OFF
cells. This approach allowed us also to estimate the approximate
half-life of the chimera protein that resulted to be about 8 h.
Taken together these data demonstrate that the chimera protein
NEU3-HA-GFP is fully active and that in our cell system its
expression is tightly regulated by the presence of dox in the growth
medium.
Expression of NEU3-HA-GFP specifically modifies the
cellular ganglioside composition
Since NEU3 is known as the sialidase family member that
specifically exerts its enzymatic activity toward gangliosides [6,19],
we then analyzed the sphingolipid pattern of [3H]-Sphigosine
metabolically labeled cells. OFF HeLa tTA2 NEU3-HA-GFP cells
were plated and grown for 72 h in absence or presence of dox.
Cells were then metabolically labeled in order to achieve the
steady-state equilibrium of lipid labeling. Cell lipids were extracted
and subjected to a two-phase partitioning and gangliosides and
non-ganglioside sphingolipids were separated and analyzed by
HPTLC. As shown in Figure 2A, in NEU3-HA-GFP expressing
cells a 63% and a 75% reduction in GM3 and GD1a ganglioside
content, respectively, was observed in comparison to non
expressing cells. Interestingly, an increase in GM1 content was
also detected in NEU3-HA-GFP expressing cells while GM2
content did not seem to change in the experimental conditions
tested. Moreover, a statistically significant increase of lactosyl-
ceramide (Lac-Cer), about 43%, was found after NEU3-HA-GFP
expression (Figure 2B). No significant variation of the other
sphingolipids, i.e. ceramide (Cer), glucosyl-ceramide (Glc-Cer),
sphingomyelin (SM) and Gb3, was detected. Changes in the
sphingolipid content could be specifically ascribed to the
expression of NEU3-HA-GFP since no significant differences in
the transcript content of endogenous sialidases, namely NEU1 and
NEU3, could be observed in transfected cells grown in presence or
absence of dox and compared to non transfected cells (Figure S1).
NEU3-HA-GFP is associated to both DRM and non-DRM
In order to study the association of NEU3-HA-GFP to different
membrane domains, HeLa tTA2 NEU3-HA-GFP cells were
grown for 72 h in absence of dox and extracted for 30 min at 4uC
in the appropriate buffer, i.e. either containing or not 1% Triton
X-100. Cell extracts were then subjected to ultracentrifugation for
1 h at 100,0006g, and NEU3-HA-GFP distribution between
supernatant and pelleted material was compared to the DRM
marker caveolin-1 (Cav-1) and the non-DRM marker Transferrin
receptor (TfR) (Figure 3A). Treatment with cold Triton X-100
resulted in an almost equal distribution of the enzyme between
detergent-insoluble and -soluble fractions, indicating that NEU3-
HA-GFP is associated to different membrane subsets that show
different sensitivity to detergents, possibly representing DRM and
non-DRM, respectively. In order to better understand the
mechanism of association of NEU3-HA-GFP to the detergent
insoluble membranes, cells were grown for 1 h in presence of
methyl-beta-cyclodextrin before harvesting, in order to extract
cholesterol from cellular membranes, thus impairing DRM
organization. Under these experimental conditions, NEU3-HA-
GFP was exclusively detected in the soluble fraction indicating that
its association to DRM is dependent on the presence of cholesterol
(Figure 3A). As expected for a cholesterol-binding protein such as
Cav-1 [20,21], a partial solubilization of the DRM marker was
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observed after cholesterol depletion, suggesting the possibility that,
at least, a fraction of the protein is associated to DRM in a
cholesterol-independent manner [22].
These data demonstrate that sialidase NEU3-HA-GFP is
associated to different membrane subsets, i.e. one pool of the
protein is associated to detergent-sensitive membranes, and a
second pool is associated to detergent-insensitive and cholesterol-
sensitive membranes.
Newly synthesized NEU3-HA-GFP is initially associated to
non-DRM
In order to better characterize the membrane subcompartments
to which NEU3-HA-GFP is associated, OFF HeLa tTA2 NEU3-
HA-GFP cells were shifted to ON conditions for different time
periods and the distribution of the enzyme was analyzed after
Triton X-100 extraction and discontinuous Opti-Prep density
gradient separation. The distribution of NEU3-HA-GFP was
Figure 1. Characterization of the inducible expression cell model HeLa tTA2 NEU3-HA-GFP. (A) HeLa tTA2 cells stably transfected with
pUHD 10.3 NEU3-HA-GFP or with the empty vector (mock) were grown for 7 days in absence (ON) or presence (OFF) of dox. Cell homogenates were
analyzed for sialidase activity (values are given as mean +/2 SD and represent the mean of 5 independent experiments) and for NEU3-HA-GFP
expression using anti-HA primary antibody. Alpha-tubulin was detected with specific primary antibody in order to normalize NEU3-HA-GFP signal. (B)
OFF HeLa tTA2 NEU3-HA-GFP were plated and grown in absence of dox for the indicated time periods. Cell homogenates were analyzed for sialidase
activity (values refer to ON cells and represent the mean +/2 SD of 4 independent experiments) and NEU3-HA-GFP expression using anti-HA primary
antibody. NEU3-HA-GFP optical density was normalized to alpha-tubulin as indicated in (A) and values are given. (C) ON HeLa tTA2 NEU3-HA-GFP
were plated and grown in presence of dox for the indicated time periods. Cell homogenates were analyzed for sialidase activity and NEU3-HA-GFP
expression as indicated in (B). Asterisk indicates the sialidase activity measured in OFF cells.
doi:10.1371/journal.pone.0099405.g001
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analyzed in all gradient fractions and is shown in Figure 3B. As
expected, Cav-1 was detected only in the light fractions (fractions
2-3), while TfR was detected exclusively in the dense fractions
(fractions 6-8), demonstrating that a correct separation between
DRM and non-DRM was achieved. Interestingly, after 8 h
expression the newly synthesized NEU3-HA-GFP was recovered
exclusively in non-DRM fractions and only after 16 h expression
we could detect the protein also in the DRM fractions. Prolonging
the NEU3-HA-GFP expression period resulted in the full
expression at 72 h and in the equal distribution of the protein
between DRM and non-DRM. It is worth to note that the 1:1
distribution of the protein between DRM and non-DRM fractions
is reached already at 48 h expression (Figure 3C). Taken together
these data clearly demonstrate that during its biosynthesis NEU3-
HA-GFP is initially associated to non-DRM and that the equal
repartition of the protein between DRM and non-DRM
membrane subcompartments is achieved before reaching the
maximum level of expression of the enzyme.
Newly synthesized NEU3-HA-GFP specifically modifies
the ganglioside pattern of DRM and non-DRM
To investigate whether newly-synthesized NEU3-HA-GFP is
specifically active toward gangliosides of DRM and non-DRM
areas, OFF NEU3-HA-GFP transfected cells were metabolically
labeled for 2 h with [3H]Sphingosine and, after a 24 h chase, dox
was removed and cells were further cultured up to 72 h to allow
NEU3-HA-GFP expression. Cells were collected after different
time periods, extracted in presence of Triton X-100 and subjected
to Opti-Prep density gradient fractionation. Equal aliquots of
fractions 2 and 3, representing DRM, and of fractions 6, 7 and 8,
representing non-DRM, were pooled and ganglioside and neutral
sphingolipids were extracted and separated as described in
Methods. We found a significant reduction in the radioactivity
associated to GM3 and GD1a in non-DRM fractions already after
8 h expression (Figure 4). This reduction progressively went on
with NEU3-HA-GFP expression, reaching extremely low levels of
radioactivity associated to GM3 and GD1a after 72 h expression.
Correspondingly, a significant increase in Lac-Cer content in non-
DRM fractions was observed starting from 16 h, while for GM1
significance was measured after 24 h expression (Figure 4).
In the DRM membrane subcompartment, the radioactivity
associated to GM3 slowly started to decrease after 16 h of NEU3-
HA-GFP expression (Figure 4), when the protein becomes
detectable in these membrane areas. The reduction of GM3
became significant starting from 24 h expression and progressively
went on with time. Again, after 72 h expression, the radioactivity
associated to GM3 reached very low levels. Lac-Cer content of
Figure 2. Expression of NEU3 results in the modification of the cellular ganglioside composition. OFF HeLa tTA2 NEU3-HA-GFP cells
were plated and further grown for 72 h in absence (ON) or presence (OFF) of dox. Cells were then metabolically labeled for 2 h with [3H]-sphigosine
and chased for 48 h. Cell lipids were extracted and gangliosides (A) and non-ganglioside sphingolipids (B) were separated by HPTLC and visualized
(left, Beta-Imager 2000) and associated radioactivity was determined (right, Beta-Vison). Values are given as percentage of total radioactivity and
represent the means 6 S.D. of 5 independent experiments. *p,0.05; **p,0.01.
doi:10.1371/journal.pone.0099405.g002
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DRM increased starting from 16 h of sialidase expression, with
minor changes during further expression of NEU3-HA-GFP.
Radioactivity associated to GD1a and GM1 in DRM did not seem
to change significantly up to 48 h expression of NEU3-HA-GFP.
Nevertheless, an almost complete loss of radioactivity associated to
GD1a and a significant increase in GM1 was observed after 72 h
expression of NEU3-HA-GFP. No significant variations in the
content of other gangliosides and neutral sphingolipids could be
observed, both in non-DRM and in DRM fractions (not shown).
In order to investigate whether the presence of the bulky tag
represented by GFP would influence the biological activity of
NEU3, we analyzed also the activity of the enzyme using a
chimera protein devoid of GFP. For this purpose, HeLa tTA2 cells
expressing NEU3-HA under the control of the tetracycline
Figure 3. Association of NEU3-HA-GFP to DRM and non-DRM. (A) ON HeLa tTA2 NEU3-HA-GFP grown for 1 h in absence or presence of beta-
cyclodextrine were extracted in the appropriate buffer, containing or not 1% Triton X-100 for 30 min at 4uC and ultracentrifuged for 1 h at
100,0006g, Equal amounts of total (T), supernatant (SN) and pelleted (P) material was analyzed by western blot using anti-HA, anti-Transferrin
Receptor (TfR) and anti-caveolin-1 (Cav-1) primary antibodies. (B) OFF HeLa tTA2 NEU3-HA-GFP were grown in absence of dox for the indicated time
periods and extracted in the appropriate buffer containing 1% Triton X-100 for 30 min at 4uC. DRM and non-DRM were separated by Opti-Prep
density gradient centrifugation. Equal amounts of each gradient fraction were analyzed by western blot as indicated in (A). (C) Relative distribution of
NEU3-HA-GFP between DRM (fractions 2 and 3) and non-DRM (fractions 6 to 8) referred to the optical density of bands in (B).
doi:10.1371/journal.pone.0099405.g003
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promoter were established. This cell model shared the same
characteristics described for the HeLa tTA2 NEU3-HA-GFP
model, i.e. expression of the chimera protein is strictly dependent
on the absence of dox in the growth medium with a 1.5 higher
specific activity and, biosynthesis and degradation followed the
same kinetics described for the chimera NEU3-HA-GFP.
When HeLa tTA2 NEU3-HA cells were subjected to
[3H]Sphingosine labelling and further incubated for different time
periods in presence (OFF) or absence (ON) of dox, the
radioactivity associated to GM3 and GD1a, both in non-DRM
and in DRM subcompartments, decreased in relation to the time
intervals of expression of NEU3-HA (Table S1). Correspondingly,
an increase in Lac-Cer and GM1 in both subcompartments was
Figure 4. NEU3-HA-GFP specifically modifies the ganglioside pattern of non-DRM and DRM. OFF HeLa tTA2 NEU3-HA-GFP cells were
metabolically labeled for 2 h with [3H]Sphingosine and, after a 24 h chase, dox was removed for the indicated time periods. Cells were then extracted
in the appropriate buffer containing 1% Triton X-100 for 30 min at 4uC. non-DRM (upper panel) and DRM (lower panel) were separated by Opti-Prep
density gradient centrifugation. Equal aliquots of fractions 2 and 3 (DRM) and of fractions 6, 7 and 8 (non-DRM) were pooled and gangliosides and
non-ganglioside sphingolipids were extracted, separated and quantified. Values are given as percentage of total and represent the means6 S.D. of 3
independent experiments. *p,0.05; **p,0.01; ***p,0.001.
doi:10.1371/journal.pone.0099405.g004
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observed. Although the overall process of degradation of GM3 and
GD1a exerted by the two chimera proteins resulted superimpos-
able, a faster hydrolysis was observed in the case of NEU3-HA.
These observations indicate that presence of the GFP-tag does not
impair sialidase NEU3 in the recognition of its natural substrates
but only temporally delays the enzyme action toward them.
Taken together our data indicate that i) sialidase NEU3 exerts
its biological activity toward gangliosides present in the same
membrane subcompartments where the protein resides; ii)
irrespectively to the tag linked to the enzyme, sialidase NEU3
exerts its catalytic activity toward GM3 and GD1a, both in non
DRM and in DRM.
Sialidase NEU3-HA-GFP is degraded by the proteasome
We then analyzed in detail the degradation of sialidase NEU3.
For this purpose, ON HeLa tTA2 NEU3-HA-GFP cells were
shifted to OFF conditions for different time periods, extracted in
presence of Triton X-100 and subjected to Opti-Prep density
gradient fractionation. As shown in Figure 5A, incubation for 8 h
and 16 h in presence of dox resulted in a fast decrease of NEU3-
HA-GFP content. As expected, after 24 h in presence of dox only
a residual amount of protein could be detected. In detail,
densitometric analysis of the relative distribution of the protein
between DRM and non-DRM revealed that, starting from a 1:1
distribution (ON), after 16 h in presence of dox the residual
protein (about 30% compared to ON cells) is almost exclusively
present in the DRM fractions in a ratio 9:1 in favor of light
fractions (Figure 5B), indicating that the non-DRM pool of the
protein is more sensitive to the degradation process. This
distribution is maintained also after 24 h in presence of dox.
The relatively short half-life of NEU3-HA-GFP and the availabil-
ity of a regulated expression system prompted us to investigate
which process is responsible for the degradation of the protein. We
considered two main protein degradation processes, i.e. the direct
lysosomal degradation and the proteasome-mediated degradation.
For inhibiting the lysosomal degradative compartment ON HeLa
tTA2 NEU3-HA-GFP cells were incubated for up to 16 h in
presence of both dox and 10 mM NH4Cl. No significant
differences in western blot analysis (Figure 5C) as well as in
sialidase activity (data not shown) were evidenced in cell extracts
deriving from NH4Cl treated cells compared to untreated cells,
indicating that the lysosomal compartment is not involved in the
degradation of the protein. We then analyzed the involvement of
the proteasomal machinery and for this purpose ON HeLa tTA2
NEU3-HA-GFP cells were incubated for up to 16 h in presence of
both dox and 5 mM MG132, a specific proteasome inhibitor. Cell
extracts were tested for their sialidase activity and analyzed for the
presence of the protein. Under these experimental conditions, after
16 h in presence of dox and MG132 the enzymatic activity was
slightly reduced compared to ON cells (data not shown). As shown
in Figure 5C, presence of MG132 in the growth medium
significantly prevented NEU3-HA-GFP from degradation, and
after 16 h under these experimental conditions the total protein
amount was slightly reduced compared to ON cells, indicating that
the proteasomal system is responsible for the degradation of the
protein. It should be noted that MG132 acts as inhibitor of NEU3
degradation in a dose-dependent manner as shown in Figure 6.
Densitometric analysis of the distribution of NEU3-HA-GFP in
cells grown for 16 h in presence of dox and MG132 resulted in a
3:1 repartition of the protein in favor of DRM (Figure 5A and B),
further demonstrating that the non-DRM protein pool is more
sensitive to the degradation process. Preservation of NEU3-HA-
GFP by the proteasome inhibitor MG132 was also confirmed by
microscopic analysis taking advantage of the GFP tag. As shown in
Figure 5D, after 8 h in presence of dox, a significant decrease in
the GFP signal is observed, while cells grown for the same period
in presence of MG132 showed an overall signal comparable to
ON cells. It should be noted that incubation with MG132 induces
a redistribution of NEU3-HA-GFP with a significant accumula-
tion of the protein in intracellular aggregates (Figure 5D).
Treatment with MG132 is already known to cause accumulation
of different proteins in cytosolic aggregates named aggresomes
[23,24]. Moreover, accumulation of NEU3-HA-GFP in intracel-
lular aggregates was found to be reversible since treatment with
MG132 for 6 h followed by 2 h chase in normal medium re-
established the normal distribution of the protein (Figure 5D).
Overall these results demonstrate that sialidase NEU3-HA-GFP is
specifically degraded by the cellular proteasome machinery and
that the non-DRM pool of the protein is faster degraded.
Sialidase NEU3 triggers Akt phosphorylation
Overexpression of NEU3 in HeLa cells has been associated to
phosphorylation of Ras-downstream molecules [25]. Nevertheless,
this information derives from transiently transfected HeLa cells
and the analysis of intracellular signaling events was performed
only after 48 h transfection, in an end-point approach. Taking
advantage of our inducible cell system, the phosphorylation of
ERK1/2 and Akt was studied in relation to NEU3 expression
levels. OFF HeLa tTA2 NEU3-HA-GFP cells were shifted to ON
conditions for different time periods and, before harvesting,
stimulated or not for 10 min with EGF. ERK1/2 phosphorylation
was found strictly dependent on the presence of the extracellular
stimuli (Figure 7, upper panel). Already after 8 h expression of
NEU3-HA-GFP, the amount of pERK1/2 is more than doubled
compared to OFF cells, with the highest increase detected after
16 h expression. A progressive decrease in pERK1/2 was
detected, reaching almost basal levels after 72 h expression. We
also analyzed the activation of Akt (Figure 7, lower panel) and
found that stimulation of NEU3-HA-GFP expressing cells resulted
in a significant increase in pAkt compared to OFF cells. Again, the
highest phosphorylation degree was detected after 16 h expression,
the time necessary for the appearance of NEU3-HA-GFP in
DRM. Interestingly, pAkt was detected also in non-stimulated
OFF cells. Moreover, expression of NEU3-HA-GFP in non-
stimulated cells was sufficient to trigger phosphorylation of Akt,
with a 2.7-fold increase after 16 h expression compared to OFF
cells.
These data demonstrate the existence of interplay between
NEU3 and pERK1/2 and pAkt, with a particular relevance for
Akt pathway, making HeLa tTA2 NEU3-HA-GFP cells a useful
model for studying the biological role played by NEU3 in the
modulation of signal transduction events.
Discussion
In late years, the concept of a supramolecular organization of
membranes has been well established [2,26,27]. This structural
organization is represented by membrane areas where specific
lipids, such as cholesterol and sphingolipids, are highly concen-
trated, and the local protein concentration, mainly represented by
GPI-anchored proteins, cholesterol-binding proteins, heterotri-
meric G-proteins and Tyrosine-kinase receptors, is low [1,2].
These characteristics brought to the definition of lipid rafts, i.e.
transient dynamic assemblies of cholesterol/sphingolipids/proteins
[1]. Importantly, the supramolecular organization and composi-
tion of cell membranes is a key feature for different biological
events such as adhesion, signaling and trafficking [26,28,29]. Due
to the high concentration in cholesterol and sphingolipids these
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Figure 5. NEU3-HA-GFP is specifically degraded by the proteasomal machinery. (A) ON HeLa tTA2 NEU3-HA-GFP were grown in presence
of dox for the indicated time periods, with or without 5 mM MG132, and extracted in the appropriate buffer containing 1% Triton X-100 for 30 min at
4uC. DRM and non-DRM were separated by Opti-Prep density gradient centrifugation. Equal amounts of each gradient fraction were analyzed by
western blot using anti-HA, anti-Transferrin Receptor (TfR) and anti-Caveolin-1 (Cav-1) primary antibodies. (B) Relative distribution of NEU3-HA-GFP
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naturally occurring membrane domains are often referred as
liquid-ordered domains [27]. A different concept relating to
membrane organization is the Detergent Resistant Membranes
(DRM) that identifies membrane structures insoluble after
exposure of the membranes to non-ionic detergents at low
temperature, also named detergent insoluble membranes [30].
DRM can be isolated from the detergent-solubilized membranes
(non-DRM) by density gradient separation. It should be noted that
while lipid rafts and liquid-ordered membranes represent physi-
ological entities of the membranes, DRM are formed only after
detergent extraction [30]. As already mentioned, cholesterol is
known to be enriched in these areas and to play a fundamental
and essential role for the existence of DRM [2]. Depletion of
cholesterol by incubating intact cells in presence of cyclodextrins
results in the disorganization of DRM. Also glycosphingolipids,
and gangliosides among them, are highly enriched in membrane
domains. In a detergent-free approach, EGFR was found in lipid
rafts and the membrane lipid composition may influence the
presence of EGFR inside lipid rafts [31]. Moreover, it has been
demonstrated that ganglioside GM3 exerts an inhibiting function
in EGFR autophosphorylation and, as consequence, activation of
intracellular cascade events [5]. In particular, it has been shown
that, in compositionally well-defined proteoliposomes, the sialic
acid residue linked at the lactosyl-moiety of ganglioside GM3 is the
key element for the regulation of EGFR activity [32].
Several lines of evidence demonstrate that overexpression and/
or silencing of enzymes involved in the ganglioside degradative
pathway can be related to cancer [12,13,33]. Sialidase NEU3 is a
peripheral membrane protein and plays a crucial role in the
regulation of ganglioside composition directly on the cell surface
[7] and its involvement in survival of human cancer cells has been
demonstrated [25]. In detail, overexpression of NEU3 gives rise to
activation of EGFR-downstream signaling, which in turn brings to
survival of different human cancer cells. The opposite occurs when
NEU3 is down-regulated by siRNA approach. Nevertheless, these
results refer to a NEU3 end-point transient expression system and
point to the increase in Lac-Cer as the main hallmark for the
activation of EGFR signaling. We decided to better characterize
the association of NEU3 to cellular membranes, its role in the local
modification of the ganglioside pattern and its involvement in cell
signaling taking advantage of an inducible-expression system.
Our cell model allowed the expression of the chimera protein
NEU3-HA-GFP as a biologically active enzyme, specifically under
the tight control of the tetracycline promoter. During its
biosynthesis the enzyme is initially found associated to non-
DRM (8 h expression) while at full expression time point (72 h) the
protein is equally distributed between DRM and non-DRM
(Figure 3). NEU3 was found associated to DRM in a cholesterol-
dependent manner, suggesting its presence in supramolecular
organized membrane structures. The molecular mechanism by
which NEU3 becomes partitioned in the two membrane domains
remains to be elucidated but it seems unlikely that appearance of
the enzyme in DRM results from the complete filling of the non-
DRM compartment and consequent transfer of the protein from
non-DRM to DRM. Indeed, the one-to-one repartition between
the two membrane areas is achieved at 48 h, thus before reaching
full expression; prolonging the expression interval to 72 h the
sialidase content of both membrane subcompartments is in-
creased. We can speculate that association of newly synthesized
NEU3-HA-GFP to DRM may result either from a post-
translational modification of the protein that may occur in the
non-DRM areas or from the association of NEU3-HA-GFP to
other membrane components (protein-protein or protein-lipid
association) that may recruit the protein to DRM.
Among sialidases, NEU3 shows high enzymatic specificity
toward gangliosides, particularly GM3 and GD1a, both in in vitro
and in in vivo systems [6–8,13,34]. [3H]-Sphingosine labeling of
ON and OFF cells demonstrated significant modifications of the
ganglioside composition of total cell membranes, particularly in
relation to a significant decrease in GM3 and GD1a content
(Figure 2). Our cell model allowed also the analysis of changes in
ganglioside composition during NEU3-HA-GFP biosynthesis and
in relation to the presence of the enzyme in DRM and non-DRM
areas. Our results clearly demonstrate that independently from the
tag linked to sialidase NEU3, the enzyme can hydrolyze both
GM3 and GD1a, regardless to the membrane subcompartment
where the protein resides. Hydrolysis of these gangliosides resulted
to be faster when sialidase NEU3 was expressed as NEU3-HA
chimera instead of NEU3-HA-GFP, particularly toward GD1a
present in DRM.
A possible explanation for this delay may reside in a sterical
hindrance exerted by the bulky GFP-tag (30 kDa) compared to
between DRM and non-DRM referred to the optical density of bands in (A). (C) ON HeLa tTA2 NEU3-HA-GFP were grown in presence of dox for the
indicated time periods, with or without NH4Cl or MG132. NEU3-HA-GFP expression was analyzed by western blot using anti-HA primary antibody.
Alpha-tubulin was detected with specific primary antibody and used as control for total protein loaded on gel. (D) ON HeLa tTA2 NEU3-HA-GFP were
plated onto glass coverslips and grown in presence of dox for 8 h, with or without MG132. In order to test reversibility effect of MG132, one sample
was incubated for 6 h with MG132, followed by 2 h chase in normal growth medium. After fixation, GFP signal was detected by laser scanning
microscope using the same settings (laser power, gain and offset) for all images.
doi:10.1371/journal.pone.0099405.g005
Figure 6. MG132 preserves NEU3-HA-GFP degradation in a dose-dependent manner. ON HeLa tTA2 NEU3-HA-GFP cells were grown in
presence of dox for 16 h, with or without MG132 at the indicated doses. NEU3-HA-GFP expression was analyzed by western blot using anti-HA
primary antibody. Alpha-tubulin was detected with specific primary antibody and used as control for total protein loaded on gel.
doi:10.1371/journal.pone.0099405.g006
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NEU3-HA (4 kDa). Indeed, presence of the GFP-tag may reduce
the possibility of the catalytic portion of the chimera protein in the
recognition of the sialic acid moiety of gangliosides, which results
in a slower hydrolysis of the gangliosidic substrates. NEU3 has
been demonstrated to be a peripheral membrane protein [10],
acting ‘‘in vivo’’ toward gangliosides exposed at the plasma
membrane of the same cells expressing NEU3 (cis-activity) but also
belonging to neighboring cells (trans-activity) [7]. Presence of the
GFP-tag may represent a steric hindrance resulting in the need of
a major structural adaptation of the enzyme in the recognition of
the glycan moiety to be hydrolyzed.
We could also demonstrate that sialidase NEU3-HA-GFP half-
life is about 8 h and its degradation occurs via the proteasome
machinery (Figure 5). In detail, in the first 8 h we observed a
similar decrease in sialidase signal both in DRM and in non-DRM
compartments, giving rise to a decrease of total NEU3-HA-GFP of
about 50% compared to ON cells. Incubation of cells for up to
24 h in presence of dox evidenced that the reduction in total
sialidase signal can be ascribed to the degradation of the protein
from the non-DRM pool. Inhibition of the proteasome for 16 h
resulted in a reduction of total sialidase activity of about 25%
compared to ON cells that can be ascribed exclusively to the non-
DRM pool. Further experiment are needed in order to elucidate
whether the non-DRM pool of the protein is more sensitive to
degradation events and/or the DRM pool is somehow protected
from degradation, maybe by the more rigid and organized
membrane environment where the protein resides. To our
knowledge this is the first example of a peripheral membrane
protein that is degraded via the proteasomal machinery. Never-
theless, the molecular mechanism by which the protein is delivered
to the proteasome requires further investigation.
Finally, the phosphorylation state of ERK1/2 and Akt at
different time of NEU3-HA-GFP expression and +/2 EGF
stimulation has been examined. ERK1/2 phosphorylation resulted
strictly dependent on EGF stimulation, with a significant increase
already at 8 h after NEU3-HA-GFP expression (Figure 7).
Activation reached its maximum at 16 h NEU3-HA-GFP
expression in presence of EGF, a time point when total sialidase
activity is nearly 50% compared to ON cells and almost only 10%
of the enzyme is present in DRM. Moreover, by this time an initial
decrease in GM3 content in these membrane areas was detected.
Similar results were obtained also for Akt phosphorylation in
presence of EGF, with an even more pronounced increase in pAkt
after 16 h NEU3-HA-GFP expression. Of particular interest is the
finding that in EGF non-stimulated cells, expression of NEU3-HA-
GFP is sufficient to trigger Akt phosphorylation. Again, even in
absence of EGF, pAkt reached a maximum after 16 h of NEU3-
HA-GFP expression, a time interval in which the enzyme
specifically modifies the sphingolipids pattern of DRM. In this
perspective, not only the activity of NEU3-HA-GFP toward
gangliosides of different membrane areas results in specific and
differential modifications of their sphingolipids pattern, but is
associated to modifications of signal transduction cascades. These
effects of NEU3 on membrane biology represent a direct link
between the enzyme and the complex series of events leading to
cancer [12,35].
In summary, NEU3 represents the first example of a peripheral
membrane protein that i) is associated both to DRM and non-
DRM, ii) exerts its enzymatic activity toward gangliosides present
therein, iii) specifically modifies their ganglioside patterns and iv) is
degraded by proteasomal machinery. Moreover, expression of
NEU3 not only enhances the phosphorylation state of signaling
molecules in response to EGF but its expression is sufficient to
trigger phosphorylation of Akt per se. Use of proteasome
inhibitors/activators and dextrins may represent a possible
strategy for regulating the amount of total NEU3 and its presence
in DRM and non-DRM. This approach is now under investiga-
tion on several tumor cells in our laboratory.
Supporting Information
Figure S1 Expression of NEU3-HA-GFP does not influ-
ence the expression of endogenous NEU1 and NEU3.
Mock and HeLa tTA2 NEU3-HA-GFP cells were grown for 72 h
in presence or absence of dox. Total RNA was extracted and
0.8 mg of RNA were retro-transcribed. Amplification of endoge-
nous NEU1 and NEU3 was performed and the fold change
expression of the different genes in NEU3-HA-GFP overexpress-
ing cells compared with Mock cells was normalized to the
expression of glyceraldeide 3-phosphate dehydrogenase (GAPDH)
mRNA and was calculated by the equation 22DDCt. Values are
given as NEU3-HA-GFP relative expression and represent the
means 6 S.D. of 3 independent experiments.
(TIF)
Table S1 NEU3-HA modifies the ganglioside pattern of
non-DRM and DRM faster than NEU3-HA-GFP. OFF
HeLa tTA2 NEU3-HA-GFP cells were metabolically labeled for
2 h with [3H]Sphingosine and, after a 24 h chase, dox was
removed for the indicated time periods. Cells were then extracted
in the appropriate buffer containing 1% Triton X-100 for 30 min
at 4uC. non-DRM and DRM were separated by Opti-Prep density
gradient centrifugation. Equal aliquots of fractions 2 and 3 (DRM)
and of fractions 6, 7 and 8 (non-DRM) were pooled and
gangliosides and non-ganglioside sphingolipids were extracted,
separated and quantified. Values are given as percentage of total.
(DOCX)
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Figure 7. NEU3-HA-GFP triggers phosphorylation of ERK1/2
and Akt. OFF HeLa NEU3-HA-GFP cells were plated and switched ON
for the indicated time periods. 24 h before treatment cells were grown
in absence of serum. Before harvesting, cells were stimulated or not for
10 min with EGF. Cell extracts were analyzed for pERK/ERK and pAkt/
Akt by western blot using specific primary antibodies. pERK and pAkt
optical densities were normalized to ERK and Akt, respectively, and
values are given.
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